BlackRock Advisors’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-9,174
Closed -$31K 3678
2015
Q1
$31K Buy
9,174
+1,631
+22% +$5.51K ﹤0.01% 3323
2014
Q4
$26K Hold
7,543
﹤0.01% 3389
2014
Q3
$38K Hold
7,543
﹤0.01% 3291
2014
Q2
$104K Buy
+7,543
New +$104K ﹤0.01% 2995